Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Classification criteria for mild cognitive impairment: a population-based validation study.

K Ritchie1, S Artero, J Touchon

  • 1Institut National de la Santé et de la Recherche Médicale, INSERM E99 30 Epidemiology of Nervous System Pathologies, Montpellier, France.

Neurology
|January 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nanolithium, a New Treatment Approach to Alzheimer's Disease: A Review of Existing Evidence and Clinical Perspectives.

The journal of prevention of Alzheimer's disease·2024
Same author

Editorial: What Is Reasonable and Necessary for Alzheimer Patients from Randomized Clinical Trials to Clinical Practice?

The journal of prevention of Alzheimer's disease·2023
Same author

The APPLE Tree programme: Active Prevention in People at risk of dementia through Lifestyle, bEhaviour change and Technology to build REsiliEnce-randomised controlled trial.

Trials·2022
Same author

The Future of AD Clinical Trials with the Advent of Anti-Amyloid Therapies: An CTAD Task Force Report.

The journal of prevention of Alzheimer's disease·2022
Same author

Can We Distinguish Age-Related Frailty from Frailty Related to Diseases ? Data from the MAPT Study.

The journal of nutrition, health & aging·2020
Same author

Non-Amyloid Approaches to Disease Modification for Alzheimer's Disease: An EU/US CTAD Task Force Report.

The journal of prevention of Alzheimer's disease·2020

Diagnostic criteria for mild cognitive impairment (MCI) show poor predictive validity and temporal stability in the general population. Current criteria may need modification to better detect early dementia.

Area of Science:

  • Gerontology
  • Neurology
  • Epidemiology

Background:

  • Mild cognitive impairment (MCI) is proposed as a precursor to dementia in the elderly.
  • Existing MCI diagnostic criteria, developed from small clinical groups, lack validation in the general population.
  • The temporal stability and predictive accuracy of MCI criteria are under scrutiny.

Purpose of the Study:

  • To assess the predictive validity of current diagnostic criteria for mild cognitive impairment (MCI).
  • To evaluate the temporal stability of MCI diagnostic criteria in a longitudinal population study.
  • To compare MCI with age-associated cognitive decline (AACD) in predicting dementia.

Main Methods:

  • A longitudinal population study identified subjects meeting MCI and AACD criteria across three waves.

Related Experiment Videos

  • Standardized neurologic examinations were administered to all participants.
  • Discriminant function analysis was used to assess group homogeneity.

    • Main Results:

    • MCI prevalence was 3.2% and AACD 19.3% in the general population.
    • MCI was a poor predictor of dementia (11.1% conversion rate) and highly unstable over time.
    • AACD, contrary to expectations, showed higher stability and a significant dementia conversion rate (28.6%, RR=21.2).

    Conclusions:

    • Current MCI diagnostic criteria demonstrate poor performance in a representative population.
    • The instability and low predictive value of MCI criteria necessitate revisions.
    • Modified criteria are proposed to enhance the detection of incipient dementia.